Related Experiment Video
Updated: Aug 4, 2026
14:24
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
[Pulmonary toxicity of amiodarone]
Revista Clinica Espanola
|November 1, 1989
Summary
This case study details amiodarone-induced lung disease, identifying key diagnostic markers. Lymphocytosis in bronchoalveolar lavage and dense lamellar bodies in lung tissue are crucial for diagnosing amiodarone pneumopathy.
Area of Science:
- Pulmonology
- Toxicology
- Pathology
Background:
- Amiodarone is an antiarrhythmic drug with known pulmonary toxicity.
- Drug-induced lung disease can present with varied clinical and pathological features.
Observation:
- A case of amiodarone-induced lung disease was investigated using comprehensive diagnostic methods.
- Analysis included epidemiological, clinical, radiological, and pathological evaluations.
- Bronchoalveolar lavage (BAL) and electron microscopy were key investigative tools.
Findings:
- Pulmonary tissue showed elevated iodine levels (2 p.p.m.) not found in normal lung tissue.
- Bronchoalveolar lavage revealed significant lymphocytosis.
- Electron microscopy identified dense lamellar bodies within the affected lung tissue.
Implications:
- Lymphocytosis in BAL fluid and the presence of dense lamellar bodies are critical diagnostic indicators for amiodarone pneumopathy.
- Early and accurate diagnosis is essential for managing amiodarone-induced lung injury.
- This case highlights the importance of considering amiodarone toxicity in patients with unexplained pulmonary disease.
More Related Videos
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:16Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
01:18Pulmonary Edema II: Pathophysiology
Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...